Immunomodulating Agents
Home > API Products > Immunomodulating Agents

Ozanimod Hydrochloride
- Category Multiple Sclerosis; Ulcerative Colitis
- CAS 1618636-37-5
- Specification In-house
- US DMF 37597
- CEP / Other DMF N/A
- GMP certification TFDA
- Inspection TFDA
- StatusCommercial
- Major Market US, EU, Japan